http://ift.tt/eA8V8J
InSphero has entered into an agreement with Pfizer Inc., one of the world’s premier biopharmaceutical companies, to develop a novel predictive toxicology assay using InSphero 3D InSight Human Liver Microtissues.
April 27, 2017 at 09:20PM
http://ift.tt/2qjto5V
from Startupticker
http://ift.tt/2qjto5V